Skip to main content

Supplementary Figure S5 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration

Publication ,  Other
Ludwig, AL; McKay, ZP; Carter, GP; Katz, MA; Howell, G; Jain, V; Arvai, S; Dittmer, DP; Bigner, DD; Ashley, DM; Shoaf, ML; Desjardins, A ...
February 3, 2026

<p>Supplementary Figure S5. PVSRIPO is shed in phosphatidyl-serine enriched vesicles from A375 melanoma cells (extended data relating to Figure 4G).</p>

Duke Scholars

DOI

Publication Date

February 3, 2026
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Ludwig, A. L., McKay, Z. P., Carter, G. P., Katz, M. A., Howell, G., Jain, V., … Gromeier, M. (2026). Supplementary Figure S5 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. https://doi.org/10.1158/2326-6066.31239119
Ludwig, Andrea L., Zachary P. McKay, Griffin P. Carter, Mark A. Katz, Georgia Howell, Vaibhav Jain, Stephanie Arvai, et al. “Supplementary Figure S5 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration,” February 3, 2026. https://doi.org/10.1158/2326-6066.31239119.
Ludwig AL, McKay ZP, Carter GP, Katz MA, Howell G, Jain V, Arvai S, Dittmer DP, Bigner DD, Ashley DM, Shoaf ML, Desjardins A, Gregory SG, Brown MC, Gromeier M. Supplementary Figure S5 from Lymphotropic Virotherapy Induces DC and High Endothelial Venule Inflammation, Promoting the Antitumor Efficacy of Intratumor Virus Administration. 2026.

DOI

Publication Date

February 3, 2026